A Study of Loco-Regional Liposomal Bupivacaine Injection
Reason given: Lack of funds
Key facts
- Where
- Eau Claire, United StatesSee the site
- Phase
- Phase 4
Where in United States
- Mayo Clinic Health System-Eau ClaireEau Claire, United StatesNo longer taking part
Trial details
- Who runs it
- Mayo Clinic
- Trial code
- NCT05992896
- Record updated
- 29 May 2026
- Original description
The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.Read full original descriptionShow less
Can Loco-regional Anesthesia With Liposomal Bupivacaine Reduce Intra- and Post-operative Narcotic Use in Patients Undergoing Lower Extremity Revascularization? A Prospective, Triple Blinded, Randomized Trial.
The purpose of this research is to find out if using liposomal bupivacaine solution (bupivacaine liposome) injections during lower extremity revascularization surgery will lower the amount of narcotic drugs used during and following the procedure.
Inclusion: Those who present for elective lower extremity revascularization.
Exclusion: Use of spinal or epidural for surgery; Allergy to local anesthetics; Non-English speaking; Chronic pain; On opioids greater than 1 weeks; Lack of patient cooperation; Contraindication to regional anesthesia; Vulnerable individuals; Urgent/emergent surgeries; Known to be pregnant or able to become pregnant.